MarketPeel
Insider Trading Intelligence
KW

Karen J. Wilson

SER
DIRECTOR · SERINA THERAPEUTICS, INC. · CIK 0001267490
FILING MIX · LIFETIME100%/0%
BUYS
10
SELLS
0
TOTAL VALUE
$54.7K
COMPANIES
2
ACTIVE SINCE
Dec 2023
HOLDINGS NOW
23,150
AVG SELL PX
TRADE KIND
SHOWING 10 / 10
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Karen J. Wilson. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
SER · 15,250 shares · as of Jun 17, 2026
010,00020,00030,00040,0002026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 10 buys / 0 sellsCOVERAGE · 11 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SER
SERINA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,25015,250Jun 17, 2026Jun 22, 2026View →
SER
SERINA THERAPEUTICS, INC.
PURCHASE
5,000$1.77$8.8K10,100Jun 12, 2026Jun 15, 2026View →
SER
SERINA THERAPEUTICS, INC.
PURCHASE
5,100$1.75$8.9K5,100Jun 11, 2026Jun 15, 2026View →
SER
SERINA THERAPEUTICS, INC.
PURCHASE
10,000$1.93$19.3K20,000May 22, 2026May 26, 2026View →
SER
SERINA THERAPEUTICS, INC.
PURCHASE
10,000$1.77$17.7K10,000May 21, 2026May 26, 2026View →
SER
SERINA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Nov 7, 2025Nov 10, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,9007,900May 19, 2025May 20, 2025View →
SER
SERINA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Jan 14, 2025Jan 14, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,1004,100Nov 21, 2024Nov 25, 2024View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,1004,100Dec 28, 2023Dec 28, 2023View →
Other insiders · SER
Loading peer insiders…
About this filer
CIK 0001267490
ROLE
Director
PRIMARY
SER
COMPANIES
2
ACTIVE SINCE
Dec 2023
MARKETPEEL · /INSIDER/0001267490DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback